company background image
CMAX

CareMax NasdaqGS:CMAX Stock Report

Last Price

US$4.83

Market Cap

US$422.0m

7D

-5.8%

1Y

-63.6%

Updated

24 Jun, 2022

Data

Company Financials +
CMAX fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health2/6
Dividends0/6

CMAX Stock Overview

CareMax, Inc. provides medical services through physicians and health care professionals.

CareMax Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for CareMax
Historical stock prices
Current Share PriceUS$4.83
52 Week HighUS$14.29
52 Week LowUS$3.53
Beta0
1 Month Change-2.23%
3 Month Change-39.93%
1 Year Change-63.60%
3 Year Changen/a
5 Year Changen/a
Change since IPOn/a

Recent News & Updates

Shareholder Returns

CMAXUS HealthcareUS Market
7D-5.8%7.7%6.6%
1Y-63.6%2.5%-18.5%

Return vs Industry: CMAX underperformed the US Healthcare industry which returned 2.8% over the past year.

Return vs Market: CMAX underperformed the US Market which returned -20.5% over the past year.

Price Volatility

Is CMAX's price volatile compared to industry and market?
CMAX volatility
CMAX Average Weekly Movement15.2%
Healthcare Industry Average Movement9.2%
Market Average Movement8.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.1%

Stable Share Price: CMAX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: CMAX's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a1,270Carlos de Solohttps://www.caremax.com

CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States.

CareMax Fundamentals Summary

How do CareMax's earnings and revenue compare to its market cap?
CMAX fundamental statistics
Market CapUS$421.99m
Earnings (TTM)-US$24.77m
Revenue (TTM)US$404.76m

1.0x

P/S Ratio

-17.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CMAX income statement (TTM)
RevenueUS$404.76m
Cost of RevenueUS$361.01m
Gross ProfitUS$43.76m
Other ExpensesUS$68.53m
Earnings-US$24.77m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.28
Gross Margin10.81%
Net Profit Margin-6.12%
Debt/Equity Ratio23.6%

How did CMAX perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is CMAX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CMAX?

Other financial metrics that can be useful for relative valuation.

CMAX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.2x
Enterprise Value/EBITDA-23x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CMAX's PS Ratio compare to its peers?

CMAX PS Ratio vs Peers
The above table shows the PS ratio for CMAX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average2.6x

Price-To-Sales vs Peers: CMAX is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (2.6x).


Price to Earnings Ratio vs Industry

How does CMAX's PE Ratio compare vs other companies in the U.S. Healthcare Industry?

Price-To-Sales vs Industry: CMAX is good value based on its Price-To-Sales Ratio (1x) compared to the US Healthcare industry average (1.4x)


Price to Sales Ratio vs Fair Ratio

What is CMAX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CMAX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1x
Fair PS Ratio2x

Price-To-Sales vs Fair Ratio: CMAX is good value based on its Price-To-Sales Ratio (1x) compared to the estimated Fair Price-To-Sales Ratio (2x).


Share Price vs Fair Value

What is the Fair Price of CMAX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CMAX's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CMAX's fair value for valuation analysis.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CMAX's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is CareMax forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-38.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CMAX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CMAX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CMAX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CMAX's revenue (31.7% per year) is forecast to grow faster than the US market (8.3% per year).

High Growth Revenue: CMAX's revenue (31.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CMAX is forecast to be unprofitable in 3 years.


Discover growth companies

Past Performance

How has CareMax performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-66.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CMAX is currently unprofitable.

Growing Profit Margin: CMAX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CMAX is unprofitable, and losses have increased over the past 5 years at a rate of 66% per year.

Accelerating Growth: Unable to compare CMAX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CMAX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (9.6%).


Return on Equity

High ROE: CMAX has a negative Return on Equity (-5.03%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is CareMax's financial position?

Financial Health Score

2/6

Financial Health Score 2/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: CMAX's short term assets ($107.7M) exceed its short term liabilities ($28.1M).

Long Term Liabilities: CMAX's short term assets ($107.7M) do not cover its long term liabilities ($128.8M).


Debt to Equity History and Analysis

Debt Level: CMAX's net debt to equity ratio (16.9%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if CMAX's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: CMAX's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if CMAX's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Dividend

What is CareMax current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate CMAX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CMAX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CMAX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CMAX's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CMAX has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

0.2yrs

Average management tenure


CEO

Carlos de Solo (42 yo)

11.08yrs

Tenure

US$1,641,599

Compensation

Mr. Carlos A. de Solo is a Co-Founder of CareMax Medical Group, L.L.C., and serves as President, Chief Executive Officer and Director since May 2011. Mr. de Solo has experience in the healthcare industry....


CEO Compensation Analysis

Compensation vs Market: Carlos's total compensation ($USD1.64M) is below average for companies of similar size in the US market ($USD2.71M).

Compensation vs Earnings: Carlos's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CMAX's management team is not considered experienced ( 0.2 years average tenure), which suggests a new team.


Board Members

Experienced Board: CMAX's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.4%.


Top Shareholders

Company Information

CareMax, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: CareMax, Inc.
  • Ticker: CMAX
  • Exchange: NasdaqGS
  • Founded: NaN
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: US$421.987m
  • Shares outstanding: 87.37m
  • Website: https://www.caremax.com

Number of Employees


Location

  • CareMax, Inc.
  • 1000 NW 57 Court
  • Suite 400
  • Miami
  • Florida
  • 33126
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/24 00:00
End of Day Share Price2022/06/24 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.